Replies to post #494326 on Anavex Life Sciences Corp (AVXL)

[LakeshoreLeo1953]

At issue, I think greatly misrepresented here, is what happened to 90 day time limit to answer?

Too many think Anavex is just being deliberate responding.
I read 8/1 as exceeding 90 days.

[Investor2014]

Pointing to the shortcomings of other treatments doesn’t excuse the deficiencies of an application like Anavex’s. Each submission must stand on its own merits, as we've seen with previous EMA reviews of monoclonal antibody applications.

[gerry57]

I didn’t find the abstract in order to disparage the mabs , I was looking for insight as to what chimp might ask. I think the risk reward benefit of Blarcamesine warrants EU approval, we’ll see.

[LakeshoreLeo1953]

Gerry’s Link

[powerwalker]

Note for all: This is dated May 2019. Lots has changed in the last 6 years.